Low-molecular-weight heparin during pregnancy and delivery: Preliminary experience with 41 pregnancies

Obstetrics and Gynecology

Volumn 87, Issue 3, 1996, Pages 380-383

  Dulitzki, Mordechai ^b   Pauzner, Rachel ^b   Langevitz, Pnina ^b   Pras, Mordechai ^b   Many, Amira ^b   Schiff, Eyal ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; ARTICLE; CLINICAL ARTICLE; EPIDURAL ANESTHESIA; FEMALE; FETUS DEATH; GESTATIONAL AGE; HUMAN; PERINATAL CARE; PREGNANCY COMPLICATION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOEMBOLISM; VAGINA BLEEDING;

EID: 0029928051     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/0029-7844(95)00452-1     Document Type: Article

References (12)

1. Leyvraz PF, Bachmann F, Hoek J, Buller HR, Postel M, Samama M, et al. Prevention of deep vein thrombosis after hip replacement: Randomized comparison between unfractionated heparin and low-molecular-weight heparin. BMJ 1991;303:543-8.
2. The German Hip Arthroplasty Trial Group. Prevention of deep vein thrombosis with low molecular weight heparin in patients undergoing total hip replacement: A randomized trial. Arch Orthop Trauma Surg 1992;111:110-20.
3. Fejgin MD, Lourwood DL. Low molecular weight heparins and their use in obstetrics and gynecology. Obstet Gynecol Surv 1994;49:424-31.
4. Matzsch T, Bergqvist D, Bergqvist A, Hodson S, Dawes J, Hedner U, et al. No transplacental passage of heparin or an enzymatically depolymerized low molecular weight heparin. Blood Coagul Fibrinolysis 1991;2:273-8.
5. Omri A, Delaloye JF, Anderson H, Bachmann F. LMW heparin Novo (LHN-1) does not cross the placenta during the second trimester of pregnancy. Thromb Haemost 1989;61:55-6.
6. Saivin S, Giroux M, Dumas JC, Faure F, Rekik L, Grandjean H, et al. Placental transfer of glycosaminoglycans in the human perfused placental cotyledon model. Eur J Obstet Gynecol Reprod Biol 1991;42:221-5.
7. Sturridge F, De Swiet M, Letsky E. The use of low molecular weight heparin for thromboprophylaxis in pregnancy. Br J Obstet Gynaecol 1994;101:69-71.
8. Phillips JK, Majumdar G, Hunt BJ, Savidge GF. Heparin-induced skin reaction due to two different preparations of low molecular weight heparin (LMWH). Br J Haematol 1993;84:349-50.
9. Kandrotas RJ. Heparin pharmacokinetics and pharmacodynamics. Clin Pharmacokinet 1992;22:359-74.
10. Handeland GF, Abidgaard GF, Holm U, Arnesen KE. Dose adjusted heparin treatment of deep venous thrombosis: A comparison of unfractionated and low molecular weight heparin. Eur J Clin Pharmacol 1990;39:107-12.
11. Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M, et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 1995;332:1330-5.
12. Melissari E, Parker CJ, Wilson NV, Monte G, Kanthou G, Pemberton KD, et al. Use of low molecular weight heparin in pregnancy. Thromb Haemost 1992;68:652-6.